Healthequity Stock Market Sentiment

HQY
 Stock
  

USD 60.68  1.85  3.14%   

Healthequity investor sentiment overview provides quick insight into current market opportunities from investing in Healthequity. The current market sentiment together Healthequity's historical and current headlines can help investors to time the market. Many technical investors use Healthequity stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please check Healthequity Hype Analysis, Healthequity Correlation and Healthequity Performance.
  
Refresh
Healthequity stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Healthequity daily returns and investor perception about the current pice of Healthequity as well as its diversification or hedging effects on your existing portfolios.

Healthequity Latest Sentiment Indicators

200 Day MA
59.06
Short Percent
0.0567
Short Ratio
5.89
Shares Short Prior Month
3.8 M
50 Day MA
62.76
52 Week Low
36.81
Shares Short
4.2 M

Healthequity Current Investor Sentiment

Investor biases related to Healthequity's public news can be used to forecast risks associated with investment in Healthequity. The trend in average sentiment can be used to explain how an investor holding Healthequity can time the market purely based on public headlines and social activities around Healthequity. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Healthequity's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Healthequity's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Healthequity's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Healthequity.

Healthequity Maximum Pain Price across 2022-07-15 Option Contracts

Healthequity's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Healthequity close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Healthequity's options.
over three months ago at www.benzinga.com         
Earnings Outlook For HealthEquity - Benzinga - Benzinga
benzinga news
over three months ago at simplywall.st         
An Intrinsic Calculation For HealthEquity, Inc. Suggests Its 29 percent Undervalued - Simply Wall St
Simply Wall St News at Macroaxis
over three months ago at www.biocentury.com         
Biotechs new sources of capital want social impact, health equity - BioCentury
news
over three months ago at seekingalpha.com         
HealthEquity Quality Firm, But Not Likely Worth The Price - Seeking Alpha
seekingalpha News
over three months ago at www.marketbeat.com         
HealthEquity Price Target Raised to 62.00 - MarketBeat
Marketbeat News
over three months ago at simplywall.st         
Shareholders in HealthEquity have lost 36, as stock drops 10 percent this past week - Simply Wall St
Simply Wall St News at Macroaxis
over three months ago at www.marketscreener.com         
HealthEquity Reports Record HSA Sales, Asset Growth - Form 8-K - marketscreener.com
news
over three months ago at www.nasdaq.com         
Heres Why You Should Hold on to IDEXX Stock for Now - Nasdaq
nasdaq News
over three months ago at www.fiercehealthcare.com         
UCLA Health launches accelerator program to scale up health equity-focused startups - FierceHealthca...
news
over three months ago at www.ama-assn.org         
Health inequitys no accident, and fixing it will take real purpose - American Medical Association
news
over three months ago at www.fiercehealthcare.com         
A look at Blue Shield of Californias new maternal health equity initiative - FierceHealthcare
news
over three months ago at finance.yahoo.com         
Global Genes Releases 2022 Rare Disease Equity, Diversity, and Inclusion Report, Highlighting Needs ...
Yahoo News
over three months ago at www.fiercebiotech.com         
Bristol Myers Squibb doles out 8M in new grants to improve health equity with cardiovascular, oncolo...
news
over three months ago at www.lexology.com         
Tax Financial Services Week Ahead Jan. 31 - Feb. 4 - Lexology
news
over three months ago at www.macroaxis.com         
Acquisition by Parker Stuart B of 1212 shares of Healthequity subject to Rule 16b-3
Macroaxis News
There is far too much social signal, news, headlines, and media speculation about Healthequity that is available to investors today. That information is available publicly through Healthequity media outlets and privately through word of mouth or via Healthequity internal channels. However, regardless of the origin, that massive amount of Healthequity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Healthequity news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Healthequity relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Healthequity's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Healthequity alpha.

Healthequity Performance against DOW

 Price Growth (%)  
      Timeline 
1
Acquisition by Stephen Neeleman of 9535 shares of Healthequi...04/14/2022
2
Gamida Cell Announces Results of New Health Economic and Out...04/25/2022
3
EPS Estimate04/27/2022
4
Acquisition by Parker Stuart B of 1212 shares of Healthequit...04/29/2022
5
Financial Statements05/02/2022
6
Healthequity exotic insider transaction detected05/04/2022
7
New legislation calls on CMMI to create model based on healt...05/13/2022
8
Financial Statements05/16/2022
9
Pear Announces Health Equity Data Showing Similar Engagement...05/23/2022
10
EPS Reported06/06/2022
11
UnitedHealth Groups Foundation Commits 100 Million To Health...06/08/2022
12
Big Fed Rate Hike Or Very Big Hike Market Awaits - Investors...06/14/2022
13
Financial Statements06/23/2022
14
Acquisition by Parker Stuart B of 2996 shares of Healthequit...06/27/2022
Please check Healthequity Hype Analysis, Healthequity Correlation and Healthequity Performance. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
4.9 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.